Home > Insider Trading > Filing (0000899243-17-027197)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1604950	Scpharmaceuticals Inc.	SCPH	()	G7

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1591046	A/S Invest Lundbeckfond	C/O Scpharmaceuticals Inc 2400 District Avenue, Suite 310 Burlington MA 01830		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-11-21	1,544,858	$0.00	1,544,858	No	4	C	Direct
Common Stock	Acquisiton	2017-11-21	984,366	$0.00	2,529,224	No	4	C	Direct
Common Stock	Acquisiton	2017-11-21	654,762	$14.00	3,183,986	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2017-11-21	11,092,383	$0.00	1,544,858	$0.00
Common Stock	Series B Preferred Stock	Disposition	2017-11-21	7,067,945	$0.00	984,366	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct
0			No	4	C	Direct

Footnotes

Represents the total number of shares of Common Stock received by the Reporting Person upon conversion of the Issuer's Series A Preferred Stock in connection with the closing of the Issuer's initial public offering.
Represents the total number of shares of Common Stock received by the Reporting Person upon conversion of the Issuer's Series B Preferred Stock in connection with the closing of the Issuer's initial public offering.
All series of Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 7.180193-for-1 basis upon on November 21, 2017 and had no expiration date.